首页 > 最新文献

Mayo Clinic Proceedings. Digital health最新文献

英文 中文
Comparing Machine Learning and Nurse Predictions for Hospital Admissions in a Multisite Emergency Care System 比较机器学习和护士预测在多站点紧急护理系统中的入院情况
Pub Date : 2025-07-09 DOI: 10.1016/j.mcpdig.2025.100249
Jonathan Nover MBA, RN , Matthew Bai MD , Prem Tismina MS , Ganesh Raut MS , Dhavalkumar Patel MS , Girish N. Nadkarni MD, MPH , Benjamin S. Abella MD, MPhil , Eyal Klang MD , Robert Freeman DNP, RN, NE-BC

Objective

To prospectively compare nurse predictions with a machine learning (ML) model for hospital admissions and evaluate whether adding the nurse prediction to ML outputs enhances predictive performance.

Patients and Methods

In this prospective, observational study at 6 hospitals in a large mixed quaternary/community emergency department (ED) system (annual ED census ∼500,000), triage nurses recorded a binary admission prediction for adult patients. These predictions were compared with an ensemble ML model (XGBoost + Bio-Clinical BERT) trained on structured data (demographics, vital signs, and medical history) and triage text. Nurse predictions were similarly analyzed and then integrated with the ML output to assess for improvement in predictive accuracy.

Results

The ensemble ML model (XGBoost + Bio-Clinical BERT) was trained on 1.8 million historical ED visits (January 2019 to December 2023). It was then tested on 46,912 prospective ED visits with recorded nurse predictions (September 1, 2024 to October 31, 2024). In the prospective arm, nurse predictions yielded an accuracy of 81.6% (95% CI, 81.3-81.9), a sensitivity of 64.8% (63.7-65.8), and a specificity of 85.7% (85.3-86.0). At a 0.30 probability threshold, the ML model attained an accuracy of 85.4% (85.0-85.7) and a sensitivity of 70.8% (69.8-71.7). Combining nurse predictions with the ML output did not improve accuracy beyond the model alone.

Conclusion

Machine learning-based predictions outperformed triage nurse estimates for hospital admissions. These findings suggest that an admission prediction system anchored by ML can perform reliably using data available at triage.
目的前瞻性比较住院护士预测与机器学习(ML)模型,并评估将护士预测加入ML输出是否能提高预测性能。患者和方法在这一前瞻性观察性研究中,在一个大型混合季/社区急诊科(ED)系统(每年ED普查约50万)的6家医院中,分诊护士记录了成年患者的二元入院预测。这些预测与基于结构化数据(人口统计、生命体征和病史)和分类文本训练的集成ML模型(XGBoost + Bio-Clinical BERT)进行比较。护士预测也进行了类似的分析,然后与ML输出相结合,以评估预测准确性的提高。结果集成ML模型(XGBoost + Bio-Clinical BERT)对180万例ED历史就诊(2019年1月至2023年12月)进行了训练。然后对46,912名预期急诊科患者进行了测试,并记录了护士的预测(2024年9月1日至2024年10月31日)。在前瞻性组中,护士预测的准确率为81.6% (95% CI, 81.3-81.9),敏感性为64.8%(63.7-65.8),特异性为85.7%(85.3-86.0)。在0.30的概率阈值下,ML模型的准确率为85.4%(85.0-85.7),灵敏度为70.8%(69.8-71.7)。将护士预测与ML输出相结合并没有提高模型的准确性。结论:基于机器学习的预测优于医院入院分诊护士的估计。这些发现表明,基于ML的入院预测系统可以使用分诊时可用的数据可靠地执行。
{"title":"Comparing Machine Learning and Nurse Predictions for Hospital Admissions in a Multisite Emergency Care System","authors":"Jonathan Nover MBA, RN ,&nbsp;Matthew Bai MD ,&nbsp;Prem Tismina MS ,&nbsp;Ganesh Raut MS ,&nbsp;Dhavalkumar Patel MS ,&nbsp;Girish N. Nadkarni MD, MPH ,&nbsp;Benjamin S. Abella MD, MPhil ,&nbsp;Eyal Klang MD ,&nbsp;Robert Freeman DNP, RN, NE-BC","doi":"10.1016/j.mcpdig.2025.100249","DOIUrl":"10.1016/j.mcpdig.2025.100249","url":null,"abstract":"<div><h3>Objective</h3><div>To prospectively compare nurse predictions with a machine learning (ML) model for hospital admissions and evaluate whether adding the nurse prediction to ML outputs enhances predictive performance.</div></div><div><h3>Patients and Methods</h3><div>In this prospective, observational study at 6 hospitals in a large mixed quaternary/community emergency department (ED) system (annual ED census ∼500,000), triage nurses recorded a binary admission prediction for adult patients. These predictions were compared with an ensemble ML model (XGBoost + Bio-Clinical BERT) trained on structured data (demographics, vital signs, and medical history) and triage text. Nurse predictions were similarly analyzed and then integrated with the ML output to assess for improvement in predictive accuracy.</div></div><div><h3>Results</h3><div>The ensemble ML model (XGBoost + Bio-Clinical BERT) was trained on 1.8 million historical ED visits (January 2019 to December 2023). It was then tested on 46,912 prospective ED visits with recorded nurse predictions (September 1, 2024 to October 31, 2024). In the prospective arm, nurse predictions yielded an accuracy of 81.6% (95% CI, 81.3-81.9), a sensitivity of 64.8% (63.7-65.8), and a specificity of 85.7% (85.3-86.0). At a 0.30 probability threshold, the ML model attained an accuracy of 85.4% (85.0-85.7) and a sensitivity of 70.8% (69.8-71.7). Combining nurse predictions with the ML output did not improve accuracy beyond the model alone.</div></div><div><h3>Conclusion</h3><div>Machine learning-based predictions outperformed triage nurse estimates for hospital admissions. These findings suggest that an admission prediction system anchored by ML can perform reliably using data available at triage.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100249"},"PeriodicalIF":0.0,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144739648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Youth Uptake of Digital Sexual and Reproductive Health Services Across Sociodemographic Groups (2018-2022): A Total Population Study from Stockholm, Sweden 跨社会人口群体的青少年对数字性健康和生殖健康服务的吸收(2018-2022):瑞典斯德哥尔摩的一项总人口研究
Pub Date : 2025-07-08 DOI: 10.1016/j.mcpdig.2025.100251
Lovisa Hellsten MPH , Viktor H. Ahlqvist PhD , Anna M. Nielsen RM, PhD , Gunnar Brandén PhD , Anna Mia Ekström MD, PhD , Kyriaki Kosidou MD, PhD

Objective

To examine uptake of in-person and digital sexual and reproductive health (SRH) services among adolescents and young adults, quantify uptake across time, and explore whether the introduction of digital services affected the sociodemographic composition of users.

Patients and Methods

This Swedish total population study included all Stockholm residents aged 12-22 years between January 1st 2018 and December 31st 2022. The primary outcome was in-person or digital visits (chat and video) of SRH services within a year, identified using regional health care registries. Sociodemographic predictors included sex, age, migrant background, parental education, and household income, analyzed with repeated-measures multivariable regressions.

Results

Among the 454,405 individuals, 23.96% had at some point used SRH services (80.01% women) between 2018 and 2022. In-person visits remained the predominant mode of contact. Women had higher annual utilization rate of both in-person (women: 15.27%; 95% CI, 15.13-15.40; men: 1.75%; 95% CI, 1.72-1.78) and digital visits (women: 2.23%; 95% CI, 2.16-2.30; men: 0.12%; 95% CI, 0.11-0.13). Significantly lower uptake was also observed in the lowest income quintile (digital: adjusted odds ratio [aOR], 0.34; 95% CI, 0.31-0.36; in-person: aOR, 0.43; 95% CI, 0.42-0.45) compared with the highest quintile (reference group). Among digital visits, chat was more equitably used than video consultations across sociodemographic groups, including smaller differences between the highest and lowest income quintiles (chat: aOR, 0.59; 95% CI, 0.54-0.65; video: aOR, 0.25; 95% CI, 0.23-0.27). Only modest reductions in socioeconomic disparities were observed after the introduction of digital services.

Conclusions

Sociodemographic disparities in utilization were not alleviated by the introduction of digital visits; in-person users were also the primary digital users. Chat could be more equitable than video, but further research is needed.
目的调查青少年和年轻人对面对面和数字性健康和生殖健康(SRH)服务的接受情况,量化不同时间的接受情况,并探讨数字服务的引入是否影响了用户的社会人口构成。患者和方法这项瑞典总人口研究纳入了2018年1月1日至2022年12月31日期间所有12-22岁的斯德哥尔摩居民。主要结果是在一年内亲自或数字访问(聊天和视频)性健康和生殖健康服务,通过区域卫生保健登记确定。社会人口学预测因子包括性别、年龄、移民背景、父母教育程度和家庭收入,并采用重复测量多变量回归进行分析。结果在454,405人中,23.96%的人在2018年至2022年间曾使用过性健康生殖健康服务(80.01%为女性)。亲自访问仍然是主要的接触方式。女性的年使用率较高(女性:15.27%;95% ci, 15.13-15.40;男性:1.75%;95% CI, 1.72-1.78)和数字就诊(女性:2.23%;95% ci, 2.16-2.30;男性:0.12%;95% ci, 0.11-0.13)。在收入最低的五分之一人群中,吸收率也明显较低(数字校正优势比[aOR], 0.34;95% ci, 0.31-0.36;面谈:aOR, 0.43;95% CI, 0.42-0.45)与最高五分位数(参照组)相比。在数字访问中,聊天比视频咨询在社会人口统计学群体中的使用更公平,包括最高收入和最低收入五分之一之间的差异较小(聊天:aOR, 0.59;95% ci, 0.54-0.65;视频:aOR, 0.25;95% ci, 0.23-0.27)。引入数字服务后,社会经济差距仅略有缩小。结论数字就诊并不能缓解社会人口统计学上的利用差异;面对面的用户也是主要的数字用户。聊天可能比视频更公平,但还需要进一步的研究。
{"title":"Youth Uptake of Digital Sexual and Reproductive Health Services Across Sociodemographic Groups (2018-2022): A Total Population Study from Stockholm, Sweden","authors":"Lovisa Hellsten MPH ,&nbsp;Viktor H. Ahlqvist PhD ,&nbsp;Anna M. Nielsen RM, PhD ,&nbsp;Gunnar Brandén PhD ,&nbsp;Anna Mia Ekström MD, PhD ,&nbsp;Kyriaki Kosidou MD, PhD","doi":"10.1016/j.mcpdig.2025.100251","DOIUrl":"10.1016/j.mcpdig.2025.100251","url":null,"abstract":"<div><h3>Objective</h3><div>To examine uptake of in-person and digital sexual and reproductive health (SRH) services among adolescents and young adults, quantify uptake across time, and explore whether the introduction of digital services affected the sociodemographic composition of users.</div></div><div><h3>Patients and Methods</h3><div>This Swedish total population study included all Stockholm residents aged 12-22 years between January 1st 2018 and December 31st 2022. The primary outcome was in-person or digital visits (chat and video) of SRH services within a year, identified using regional health care registries. Sociodemographic predictors included sex, age, migrant background, parental education, and household income, analyzed with repeated-measures multivariable regressions.</div></div><div><h3>Results</h3><div>Among the 454,405 individuals, 23.96% had at some point used SRH services (80.01% women) between 2018 and 2022. In-person visits remained the predominant mode of contact. Women had higher annual utilization rate of both in-person (women: 15.27%; 95% CI, 15.13-15.40; men: 1.75%; 95% CI, 1.72-1.78) and digital visits (women: 2.23%; 95% CI, 2.16-2.30; men: 0.12%; 95% CI, 0.11-0.13). Significantly lower uptake was also observed in the lowest income quintile (digital: adjusted odds ratio [aOR], 0.34; 95% CI, 0.31-0.36; in-person: aOR, 0.43; 95% CI, 0.42-0.45) compared with the highest quintile (reference group). Among digital visits, chat was more equitably used than video consultations across sociodemographic groups, including smaller differences between the highest and lowest income quintiles (chat: aOR, 0.59; 95% CI, 0.54-0.65; video: aOR, 0.25; 95% CI, 0.23-0.27). Only modest reductions in socioeconomic disparities were observed after the introduction of digital services.</div></div><div><h3>Conclusions</h3><div>Sociodemographic disparities in utilization were not alleviated by the introduction of digital visits; in-person users were also the primary digital users. Chat could be more equitable than video, but further research is needed.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100251"},"PeriodicalIF":0.0,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144724163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virtual Health Care in Hospital-at-Home Models for Patients With Acute Infections: A Scoping Review 急性感染患者在医院-家庭模型中的虚拟卫生保健:范围综述
Pub Date : 2025-07-07 DOI: 10.1016/j.mcpdig.2025.100250
Maria Normand Larsen MD , Tatjana Sandreva Dreisig MD , Maja Kjær Rasmussen MSc , Anders N.Ø. Schultz MD , Thyge Lynghøj Nielsen MD, PhD , Thea K. Fischer MD, DMSc
Given the imbalance between high care demand and strained hospital capacity, hospital-at-home (HaH) models offer a potential solution by providing hospital-level care in patients’ homes. This scoping review maps the literature on hospital-led virtual health care within HaH models for acute infections, focusing on intervention characteristics and evaluation designs. Following Johanna Briggs Institute guidelines and PRISMA-ScR, we included studies on virtual and hybrid HaH models using telemedicine for remote monitoring and interventions. The literature searches were performed from October 3, 2022 to October 22, 2022, and updated on July 11, 2024 and identified 15,062 potentially relevant records. From these, 79 studies met the inclusion criteria, highlighting the diversity of HaH models and their evaluations. Hybrid models provided broader treatment options, but many studies lacked detailed intervention descriptions, complicating implementation and meta-analyses. Most studies evaluated patient outcomes, with limited attention to health care staff and relatives. Nearly 45,000 participants were assessed, but only 254 participated in randomized controlled trials, indicating a need for more high-level evidence. Relevant gaps remain, including model heterogeneity and inconsistent reporting.
鉴于高护理需求和医院能力紧张之间的不平衡,在家医院(HaH)模式通过在患者家中提供医院级别的护理提供了一个潜在的解决方案。本文综述了医院主导的虚拟卫生保健在急性感染的HaH模型中的文献,重点关注干预特征和评估设计。根据约翰娜布里格斯研究所的指导方针和PRISMA-ScR,我们纳入了使用远程医疗进行远程监测和干预的虚拟和混合HaH模型的研究。文献检索于2022年10月3日至2022年10月22日进行,并于2024年7月11日更新,确定了15062条可能相关的记录。其中,79项研究符合纳入标准,突出了HaH模型及其评估的多样性。混合模型提供了更广泛的治疗选择,但许多研究缺乏详细的干预描述,使实施和荟萃分析复杂化。大多数研究评估的是患者的预后,对医护人员和亲属的关注有限。近4.5万名参与者接受了评估,但只有254人参加了随机对照试验,这表明需要更多的高水平证据。相关差距仍然存在,包括模型异质性和不一致的报告。
{"title":"Virtual Health Care in Hospital-at-Home Models for Patients With Acute Infections: A Scoping Review","authors":"Maria Normand Larsen MD ,&nbsp;Tatjana Sandreva Dreisig MD ,&nbsp;Maja Kjær Rasmussen MSc ,&nbsp;Anders N.Ø. Schultz MD ,&nbsp;Thyge Lynghøj Nielsen MD, PhD ,&nbsp;Thea K. Fischer MD, DMSc","doi":"10.1016/j.mcpdig.2025.100250","DOIUrl":"10.1016/j.mcpdig.2025.100250","url":null,"abstract":"<div><div>Given the imbalance between high care demand and strained hospital capacity, hospital-at-home (HaH) models offer a potential solution by providing hospital-level care in patients’ homes. This scoping review maps the literature on hospital-led virtual health care within HaH models for acute infections, focusing on intervention characteristics and evaluation designs. Following Johanna Briggs Institute guidelines and PRISMA-ScR, we included studies on virtual and hybrid HaH models using telemedicine for remote monitoring and interventions. The literature searches were performed from October 3, 2022 to October 22, 2022, and updated on July 11, 2024 and identified 15,062 potentially relevant records. From these, 79 studies met the inclusion criteria, highlighting the diversity of HaH models and their evaluations. Hybrid models provided broader treatment options, but many studies lacked detailed intervention descriptions, complicating implementation and meta-analyses. Most studies evaluated patient outcomes, with limited attention to health care staff and relatives. Nearly 45,000 participants were assessed, but only 254 participated in randomized controlled trials, indicating a need for more high-level evidence. Relevant gaps remain, including model heterogeneity and inconsistent reporting.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100250"},"PeriodicalIF":0.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144748793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Tolerance to Anthracycline Chemotherapy Using Electrocardiogram-Based Artificial Intelligence in Sarcoma 利用基于心电图的人工智能预测肉瘤患者对蒽环类化疗的耐受性
Pub Date : 2025-07-04 DOI: 10.1016/j.mcpdig.2025.100247
Jack B. Korleski MD , Regina M. Koch MD , Thanh P. Ho MD , Steven I. Robinson MBBS , Scott H. Okuno MD , Joerg Herrmann MD , Brittany L. Siontis MD

Objective

The objective of this study was to understand the utility of artificial intelligence-enabled electrocardiogram (AI-ECG) to assess the tolerability of anthracycline chemotherapy.

Patients and Methods

From December 18, 2006 to October 15, 2020, we identified adults with sarcoma who were treated with anthracycline chemotherapy at our institution who had an ECG within 1 year prior to treatment initiation. Utilizing previously defined AI-ECG nomograms, we obtained age and ejection fraction (EF) predictions. Changes in AI-ECG age were correlated with chemotherapy tolerance (the rates of dose reductions, treatment delays, and early discontinuation). We measured the sensitivity and specificity of the ECG to predict an EF of less than 50% or 35% prior to treatment and compared how changes in the AI-ECG EF prediction related to changes in echocardiography-based EF.

Results

Forty patients met the eligibility criteria. Sixty-eight percent of the patients were men. The median age was 56.5 years (18-76 years). We did not find differences in chemotherapy tolerance between patients who had an elevated or decreased ECG age. There was a trend `toward higher rates of dose reductions in patients with high ECG aging (odds ratio, 5.13; P=.32). The AI-ECG low EF prediction had a sensitivity of 100% and a specificity of 94% to isolate patients with an EF of less than 50% prior to treatment. Two patients’ EF decreased more than 10% after treatment, and both cases showed significant increases in the low EF prediction.

Conclusion

Overall, AI-based predictions on ECG tracings could be a way to monitor for decreases in EF during treatment with anthracycline chemotherapy. We recommend further studies to evaluate AI-ECG aging as a marker for chemotherapy tolerance.
目的本研究的目的是了解人工智能心电图(AI-ECG)在评估蒽环类化疗耐受性方面的应用。患者和方法:从2006年12月18日至2020年10月15日,我们确定了在我们机构接受蒽环类化疗的成人肉瘤患者,他们在治疗开始前1年内有心电图。利用先前定义的AI-ECG图,我们获得了年龄和射血分数(EF)的预测。AI-ECG年龄的变化与化疗耐受性(剂量减少率、治疗延迟率和早期停药率)相关。我们测量了治疗前心电图预测EF小于50%或35%的敏感性和特异性,并比较了AI-ECG EF预测的变化与基于超声心动图的EF变化的相关性。结果40例患者符合入选标准。68%的患者是男性。中位年龄为56.5岁(18-76岁)。我们没有发现心电图年龄升高或降低的患者在化疗耐受性方面存在差异。心电图老化程度高的患者有较高剂量减量率的趋势(优势比,5.13;P =收)。AI-ECG低EF预测的敏感性为100%,特异性为94%,用于分离治疗前EF小于50%的患者。两例患者治疗后EF下降均超过10%,且两例患者的低EF预测值均显著升高。总之,基于人工智能的心电描记预测可能是监测蒽环类化疗期间EF下降的一种方法。我们建议进一步研究AI-ECG老化作为化疗耐受性的标志。
{"title":"Predicting Tolerance to Anthracycline Chemotherapy Using Electrocardiogram-Based Artificial Intelligence in Sarcoma","authors":"Jack B. Korleski MD ,&nbsp;Regina M. Koch MD ,&nbsp;Thanh P. Ho MD ,&nbsp;Steven I. Robinson MBBS ,&nbsp;Scott H. Okuno MD ,&nbsp;Joerg Herrmann MD ,&nbsp;Brittany L. Siontis MD","doi":"10.1016/j.mcpdig.2025.100247","DOIUrl":"10.1016/j.mcpdig.2025.100247","url":null,"abstract":"<div><h3>Objective</h3><div>The objective of this study was to understand the utility of artificial intelligence-enabled electrocardiogram (AI-ECG) to assess the tolerability of anthracycline chemotherapy.</div></div><div><h3>Patients and Methods</h3><div>From December 18, 2006 to October 15, 2020, we identified adults with sarcoma who were treated with anthracycline chemotherapy at our institution who had an ECG within 1 year prior to treatment initiation. Utilizing previously defined AI-ECG nomograms, we obtained age and ejection fraction (EF) predictions. Changes in AI-ECG age were correlated with chemotherapy tolerance (the rates of dose reductions, treatment delays, and early discontinuation). We measured the sensitivity and specificity of the ECG to predict an EF of less than 50% or 35% prior to treatment and compared how changes in the AI-ECG EF prediction related to changes in echocardiography-based EF.</div></div><div><h3>Results</h3><div>Forty patients met the eligibility criteria. Sixty-eight percent of the patients were men. The median age was 56.5 years (18-76 years). We did not find differences in chemotherapy tolerance between patients who had an elevated or decreased ECG age. There was a trend `toward higher rates of dose reductions in patients with high ECG aging (odds ratio, 5.13; <em>P</em>=.32). The AI-ECG low EF prediction had a sensitivity of 100% and a specificity of 94% to isolate patients with an EF of less than 50% prior to treatment. Two patients’ EF decreased more than 10% after treatment, and both cases showed significant increases in the low EF prediction.</div></div><div><h3>Conclusion</h3><div>Overall, AI-based predictions on ECG tracings could be a way to monitor for decreases in EF during treatment with anthracycline chemotherapy. We recommend further studies to evaluate AI-ECG aging as a marker for chemotherapy tolerance.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100247"},"PeriodicalIF":0.0,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144686358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence and Multi-Omics in Pharmacogenomics: A New Era of Precision Medicine 药物基因组学中的人工智能和多组学:精准医学的新时代
Pub Date : 2025-06-26 DOI: 10.1016/j.mcpdig.2025.100246
Mike Zack MD, PhD, MPH, Danil N. Stupichev MSc, Alex J. Moore BSc, Ioan D. Slobodchikov MSc, David G. Sokolov MSc, Igor F. Trifonov MSc, Allan Gobbs MSc
Pharmacogenomics is entering a transformative phase as high-throughput “omics” techniques become increasingly integrated with state-of-the-art artificial intelligence (AI) methods. Although early successes in single-gene pharmacogenetics reported clear clinical benefits, many drug response phenotypes are governed by intricate networks of genomic variants, epigenetic modifications, and metabolic pathways. Multi-omics approaches address this complexity by capturing genomic, transcriptomic, proteomic, and metabolomic data layers, offering a comprehensive view of patient-specific biology. Advanced AI models, including deep neural networks, graph neural networks, and representation learning techniques, further enhance this landscape by detecting hidden patterns, filling gaps in incomplete data sets, and enabling in silico simulations of treatment responses. Such capabilities not only improve predictive accuracy but also deepen mechanistic insights, revealing how gene–gene and gene–environment interactions shape therapeutic outcomes. At the same time, real-world data from diverse patient populations is broadening the evidence base, underscoring the importance of inclusive datasets and population-specific algorithms to reduce health disparities. Despite challenges related to data harmonization, interpretability, and regulatory oversight, the synergy between multi-omics integration and AI-driven analytics holds relevant promise for revolutionizing clinical decision-making. In this review, we highlighted key technological advances, discussed current limitations, and outlined future directions for translating multi-omics plus AI innovations into routine personalized medicine.
随着高通量“组学”技术越来越多地与最先进的人工智能(AI)方法相结合,药物基因组学正在进入一个变革阶段。尽管单基因药物遗传学的早期成功报道了明确的临床益处,但许多药物反应表型是由基因组变异、表观遗传修饰和代谢途径的复杂网络控制的。多组学方法通过捕获基因组学、转录组学、蛋白质组学和代谢组学数据层来解决这种复杂性,提供了患者特异性生物学的全面视图。先进的人工智能模型,包括深度神经网络、图形神经网络和表示学习技术,通过检测隐藏模式、填补不完整数据集中的空白,以及实现对治疗反应的计算机模拟,进一步增强了这一景观。这种能力不仅提高了预测的准确性,而且还加深了对机制的了解,揭示了基因-基因和基因-环境相互作用如何影响治疗结果。与此同时,来自不同患者群体的真实数据正在扩大证据基础,强调了包容性数据集和针对人群的算法对于减少健康差距的重要性。尽管存在与数据协调、可解释性和监管监督相关的挑战,但多组学集成和人工智能驱动分析之间的协同作用为彻底改变临床决策带来了相关希望。在这篇综述中,我们强调了关键的技术进步,讨论了当前的局限性,并概述了将多组学和人工智能创新转化为常规个性化医疗的未来方向。
{"title":"Artificial Intelligence and Multi-Omics in Pharmacogenomics: A New Era of Precision Medicine","authors":"Mike Zack MD, PhD, MPH,&nbsp;Danil N. Stupichev MSc,&nbsp;Alex J. Moore BSc,&nbsp;Ioan D. Slobodchikov MSc,&nbsp;David G. Sokolov MSc,&nbsp;Igor F. Trifonov MSc,&nbsp;Allan Gobbs MSc","doi":"10.1016/j.mcpdig.2025.100246","DOIUrl":"10.1016/j.mcpdig.2025.100246","url":null,"abstract":"<div><div>Pharmacogenomics is entering a transformative phase as high-throughput “omics” techniques become increasingly integrated with state-of-the-art artificial intelligence (AI) methods. Although early successes in single-gene pharmacogenetics reported clear clinical benefits, many drug response phenotypes are governed by intricate networks of genomic variants, epigenetic modifications, and metabolic pathways. Multi-omics approaches address this complexity by capturing genomic, transcriptomic, proteomic, and metabolomic data layers, offering a comprehensive view of patient-specific biology. Advanced AI models, including deep neural networks, graph neural networks, and representation learning techniques, further enhance this landscape by detecting hidden patterns, filling gaps in incomplete data sets, and enabling in silico simulations of treatment responses. Such capabilities not only improve predictive accuracy but also deepen mechanistic insights, revealing how gene–gene and gene–environment interactions shape therapeutic outcomes. At the same time, real-world data from diverse patient populations is broadening the evidence base, underscoring the importance of inclusive datasets and population-specific algorithms to reduce health disparities. Despite challenges related to data harmonization, interpretability, and regulatory oversight, the synergy between multi-omics integration and AI-driven analytics holds relevant promise for revolutionizing clinical decision-making. In this review, we highlighted key technological advances, discussed current limitations, and outlined future directions for translating multi-omics plus AI innovations into routine personalized medicine.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100246"},"PeriodicalIF":0.0,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144662090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence Image-Diagnosis for Female Genital Schistosomiasis 人工智能图像诊断女性生殖器血吸虫病
Pub Date : 2025-06-21 DOI: 10.1016/j.mcpdig.2025.100245
Jiayuan Zhu MSc , J. Alison Noble DPhil , Mireille Gomes DPhil

Objective

To introduce a novel, artificial Intelligence (AI), deep learning-based application for automated diagnosis of female genital schistosomiasis (FGS), a disease estimated to affect around 56 million women and girls in sub-Saharan Africa.

Patients and Methods

This study focused on cervical images collected from a high endemic FGS area in Cameroon, from August 1, 2020 to August 31, 2021. We applied the You Only Look Once deep learning model and employed a 5-fold cross-validation approach, accompanied by sensitivity analysis, to optimize model performance.

Results

The model achieved a sensitivity of 0.96 (76/78) and an accuracy of 0.78 (97/125), demonstrating improved performance over an existing, non-AI-based, computerized image diagnostic method, which has a sensitivity of 0.94 (73/78) but an accuracy of 0.58 (73/125) on the same dataset. In addition, the AI model significantly reduced processing time, decreasing from 47 minutes to under 90 seconds for testing 250 images.

Conclusion

This study highlights the potential of deep learning-based models for automated diagnosis for FGS while reducing the reliance on specialized clinical expertise. It also underscores the need for further work to address current limitations of such AI-based methods for FGS diagnosis.
目的介绍一种基于人工智能(AI)深度学习的新型应用程序,用于自动诊断女性生殖器血吸虫病(FGS),这种疾病估计影响撒哈拉以南非洲约5600万妇女和女孩。患者和方法本研究集中于2020年8月1日至2021年8月31日在喀麦隆FGS高发地区采集的宫颈图像。我们采用You Only Look Once深度学习模型,并采用5倍交叉验证方法,并辅以敏感性分析,以优化模型性能。结果该模型的灵敏度为0.96(76/78),准确度为0.78(97/125),与现有的非基于人工智能的计算机图像诊断方法相比,该模型的性能有所提高,该方法在同一数据集上的灵敏度为0.94(73/78),准确度为0.58(73/125)。此外,AI模型显著缩短了处理时间,在测试250张图像时从47分钟减少到90秒以下。本研究强调了基于深度学习的模型在FGS自动诊断中的潜力,同时减少了对专业临床专家的依赖。它还强调需要进一步开展工作,以解决目前这种基于人工智能的FGS诊断方法的局限性。
{"title":"Artificial Intelligence Image-Diagnosis for Female Genital Schistosomiasis","authors":"Jiayuan Zhu MSc ,&nbsp;J. Alison Noble DPhil ,&nbsp;Mireille Gomes DPhil","doi":"10.1016/j.mcpdig.2025.100245","DOIUrl":"10.1016/j.mcpdig.2025.100245","url":null,"abstract":"<div><h3>Objective</h3><div>To introduce a novel, artificial Intelligence (AI), deep learning-based application for automated diagnosis of female genital schistosomiasis (FGS), a disease estimated to affect around 56 million women and girls in sub-Saharan Africa.</div></div><div><h3>Patients and Methods</h3><div>This study focused on cervical images collected from a high endemic FGS area in Cameroon, from August 1, 2020 to August 31, 2021. We applied the You Only Look Once deep learning model and employed a 5-fold cross-validation approach, accompanied by sensitivity analysis, to optimize model performance.</div></div><div><h3>Results</h3><div>The model achieved a sensitivity of 0.96 (76/78) and an accuracy of 0.78 (97/125), demonstrating improved performance over an existing, non-AI-based, computerized image diagnostic method, which has a sensitivity of 0.94 (73/78) but an accuracy of 0.58 (73/125) on the same dataset. In addition, the AI model significantly reduced processing time, decreasing from 47 minutes to under 90 seconds for testing 250 images.</div></div><div><h3>Conclusion</h3><div>This study highlights the potential of deep learning-based models for automated diagnosis for FGS while reducing the reliance on specialized clinical expertise. It also underscores the need for further work to address current limitations of such AI-based methods for FGS diagnosis.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100245"},"PeriodicalIF":0.0,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144605925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthy Heart Assistant, a WhatsApp-Based Generative Pretrained Transformer Technology, for Self-Care in Hypertensive Patients 健康心脏助手,基于whatsapp的生成预训练变压器技术,用于高血压患者的自我护理
Pub Date : 2025-06-11 DOI: 10.1016/j.mcpdig.2025.100243
Samuel E. Antia MD, MSc , Collins N. Ugwu MD, MSc , Vishal Ghodka BE , Babangida S. Chori MSc , Muhammad S. Nazir MD, MSc , Chizoba A. Odili PhD , Godsent C. Isiguzo MD, PhD , Sri Vasireddy MS, MBA , Augustine N. Odili MD, PhD

Objective

To evaluate the feasibility, usability, and efficacy of innovative generative pretrained transformer chatbot in improving self-care in hypertensive patients in a resource-limited setting.

Patients and Methods

A single-arm nonblinded clinical trial was deployed in a busy cardiology clinic in a low-resource setting. Artificial intelligence–enabled chatbot (Healthy Heart Assistant) was activated in smartphones of 50 adults on treatment for hypertension. Participants were trained on how to use the Healthy Heart Assistant including setting medication and appointment reminders. Baseline questionnaires were administered at enrollment and 30 days later to explore acceptability, feasibility and usability of the bot. We used chatbot usability questionnaire and self-made Healthy Heart Assistant satisfaction questionnaire to assess bot usability and patients’ satisfaction, respectively. The study began on April 5, 2024, through July 15, 2024.

Results

Of 200 hypertensive clinic attendees, 70 (35%) had internet-enabled bot-compatible cell phones, of which 50 hypertensive patients were recruited to participate in the study. Among 50 participants, 2 (4%) were lost to follow-up; 19 (39.6%) were women; and 40 (83.3%) had attained tertiary level of education. Mean time of training to use bot was 5.7 minutes, with 35 (70.8%) of participants being able to use the bot within 5 minutes. The median frequency of chats for participants within the timeframe was an average of 1.5 chats/day. Chatbot usability questionnaire score was 69.5%, whereas self-made Healthy Heart Assistant satisfaction questionnaire score was 90%.

Conclusion

This proof-of-concept study shows that generative artificial intelligence can be applied with reasonable success in hypertension self-care in low-resource settings and has potential for being effective.
目的评价创新型生成式预训练变形聊天机器人在资源有限环境下改善高血压患者自我保健的可行性、可用性和有效性。一项单臂非盲法临床试验在一个低资源环境下繁忙的心脏病学诊所进行。在50名接受高血压治疗的成年人的智能手机上启动了人工智能聊天机器人(健康心脏助手)。参与者接受了如何使用健康心脏助手的培训,包括设置药物和预约提醒。在入组时和30天后进行基线问卷调查,以探索机器人的可接受性、可行性和可用性。采用聊天机器人可用性问卷和自制的健康心脏助手满意度问卷,分别对聊天机器人可用性和患者满意度进行评估。这项研究从2024年4月5日开始,一直持续到2024年7月15日。结果在200名高血压临床参与者中,70人(35%)拥有可上网的机器人兼容手机,其中50名高血压患者被招募参加了这项研究。在50名参与者中,2名(4%)失去随访;女性19例(39.6%);受过高等教育的40人(83.3%)。使用机器人的平均训练时间为5.7分钟,35名(70.8%)参与者能够在5分钟内使用机器人。参与者在时间框架内的聊天频率中位数平均为1.5次/天。聊天机器人可用性问卷得分为69.5%,自制健康心脏助手满意度问卷得分为90%。结论该概念验证研究表明,在资源匮乏的环境下,生成式人工智能在高血压自我保健中的应用取得了一定的成功,并且具有潜在的有效性。
{"title":"Healthy Heart Assistant, a WhatsApp-Based Generative Pretrained Transformer Technology, for Self-Care in Hypertensive Patients","authors":"Samuel E. Antia MD, MSc ,&nbsp;Collins N. Ugwu MD, MSc ,&nbsp;Vishal Ghodka BE ,&nbsp;Babangida S. Chori MSc ,&nbsp;Muhammad S. Nazir MD, MSc ,&nbsp;Chizoba A. Odili PhD ,&nbsp;Godsent C. Isiguzo MD, PhD ,&nbsp;Sri Vasireddy MS, MBA ,&nbsp;Augustine N. Odili MD, PhD","doi":"10.1016/j.mcpdig.2025.100243","DOIUrl":"10.1016/j.mcpdig.2025.100243","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the feasibility, usability, and efficacy of innovative generative pretrained transformer chatbot in improving self-care in hypertensive patients in a resource-limited setting.</div></div><div><h3>Patients and Methods</h3><div>A single-arm nonblinded clinical trial was deployed in a busy cardiology clinic in a low-resource setting. Artificial intelligence–enabled chatbot (Healthy Heart Assistant) was activated in smartphones of 50 adults on treatment for hypertension. Participants were trained on how to use the Healthy Heart Assistant including setting medication and appointment reminders. Baseline questionnaires were administered at enrollment and 30 days later to explore acceptability, feasibility and usability of the bot. We used chatbot usability questionnaire and self-made Healthy Heart Assistant satisfaction questionnaire to assess bot usability and patients’ satisfaction, respectively. The study began on April 5, 2024, through July 15, 2024.</div></div><div><h3>Results</h3><div>Of 200 hypertensive clinic attendees, 70 (35%) had internet-enabled bot-compatible cell phones, of which 50 hypertensive patients were recruited to participate in the study. Among 50 participants, 2 (4%) were lost to follow-up; 19 (39.6%) were women; and 40 (83.3%) had attained tertiary level of education. Mean time of training to use bot was 5.7 minutes, with 35 (70.8%) of participants being able to use the bot within 5 minutes. The median frequency of chats for participants within the timeframe was an average of 1.5 chats/day. Chatbot usability questionnaire score was 69.5%, whereas self-made Healthy Heart Assistant satisfaction questionnaire score was 90%.</div></div><div><h3>Conclusion</h3><div>This proof-of-concept study shows that generative artificial intelligence can be applied with reasonable success in hypertension self-care in low-resource settings and has potential for being effective.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100243"},"PeriodicalIF":0.0,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144549292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence in Digital Self-Diagnosis Tools: A Narrative Overview of Reviews 数字自我诊断工具中的人工智能:综述
Pub Date : 2025-06-10 DOI: 10.1016/j.mcpdig.2025.100242
Aikaterini Mentzou PhD , Amy Rogers MD , Edzia Carvalho PhD , Angela Daly PhD , Maeve Malone HDip , Xaroula Kerasidou PhD
Digital self-diagnosis tools, or symptom checkers, many of which incorporate artificial intelligence technology, are intended to provide diagnostic information and triage advice to lay users. This narrative overview of reviews explores the common themes and issues raised by existing evidence synthesis literature on these tools to establish a common ground for interdisciplinary research. We searched 3 bibliographic databases (PubMed, Scopus and Web of Science) and Google Scholar using keyword combinations of artificial, self-diagnosis, intelligence, and machine learning for publications from 2019 to 2023. We included systematic reviews, meta-analyses, scoping reviews, narrative syntheses, and opinion pieces that discussed tools where users proactively entered personal health information to acquire a predicted diagnosis of their symptoms or triage advice. This overview reveals significant gaps in understanding the key areas of development, implementation, impact, and oversight of digital self-diagnosis tools. Additionally, the terminology used to describe these tools and their underlying technologies varies widely, encompassing technologies ranging from simple branching logic algorithms to complex deep neural networks. Our interdisciplinary analysis identified gaps and critical areas for future research across all stages of the lifecycles of these tools. The diverse challenges uncovered highlight the necessity for multiagency and multidisciplinary efforts promoting responsible development and implementation.
数字自我诊断工具或症状检查器,其中许多都结合了人工智能技术,旨在为非专业用户提供诊断信息和分类建议。本综述探讨了现有证据综合文献中关于这些工具提出的共同主题和问题,以建立跨学科研究的共同基础。我们检索了3个书目数据库(PubMed、Scopus和Web of Science)和谷歌Scholar,使用人工、自我诊断、智能和机器学习的关键字组合检索了2019年至2023年的出版物。我们纳入了系统评价、荟萃分析、范围评价、叙述综合和意见片段,讨论了用户主动输入个人健康信息以获得对其症状的预测诊断或分诊建议的工具。这一概述揭示了在理解数字自我诊断工具的开发、实施、影响和监督的关键领域方面的重大差距。此外,用于描述这些工具及其底层技术的术语差异很大,包括从简单的分支逻辑算法到复杂的深度神经网络等技术。我们的跨学科分析确定了这些工具生命周期所有阶段的差距和未来研究的关键领域。所发现的各种挑战突出了多机构和多学科努力促进负责任的发展和执行的必要性。
{"title":"Artificial Intelligence in Digital Self-Diagnosis Tools: A Narrative Overview of Reviews","authors":"Aikaterini Mentzou PhD ,&nbsp;Amy Rogers MD ,&nbsp;Edzia Carvalho PhD ,&nbsp;Angela Daly PhD ,&nbsp;Maeve Malone HDip ,&nbsp;Xaroula Kerasidou PhD","doi":"10.1016/j.mcpdig.2025.100242","DOIUrl":"10.1016/j.mcpdig.2025.100242","url":null,"abstract":"<div><div>Digital self-diagnosis tools, or symptom checkers, many of which incorporate artificial intelligence technology, are intended to provide diagnostic information and triage advice to lay users. This narrative overview of reviews explores the common themes and issues raised by existing evidence synthesis literature on these tools to establish a common ground for interdisciplinary research. We searched 3 bibliographic databases (PubMed, Scopus and Web of Science) and Google Scholar using keyword combinations of <em>artificial</em>, <em>self-diagnosis</em>, <em>intelligence</em>, and <em>machine learning</em> for publications from 2019 to 2023. We included systematic reviews, meta-analyses, scoping reviews, narrative syntheses, and opinion pieces that discussed tools where users proactively entered personal health information to acquire a predicted diagnosis of their symptoms or triage advice. This overview reveals significant gaps in understanding the key areas of development, implementation, impact, and oversight of digital self-diagnosis tools. Additionally, the terminology used to describe these tools and their underlying technologies varies widely, encompassing technologies ranging from simple branching logic algorithms to complex deep neural networks. Our interdisciplinary analysis identified gaps and critical areas for future research across all stages of the lifecycles of these tools. The diverse challenges uncovered highlight the necessity for multiagency and multidisciplinary efforts promoting responsible development and implementation.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100242"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144534516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural Language Processing for Enhanced Clinical Decision Support in Allergy Verification for Medication Prescriptions 自然语言处理在药物处方过敏验证中的临床决策支持
Pub Date : 2025-06-10 DOI: 10.1016/j.mcpdig.2025.100244
Juan Pablo Botero-Aguirre MS , Michael Andrés García-Rivera MS

Objective

To develop and validate a named entity recognition (NER) model based on BERT-based model trained on Spanish-language corpor, for extracting allergy-related information from unstructured electronic health records.

Patients and Methods

The model was fine-tuned using 16,176 manually annotated allergy-related entities from anonimized patient records (hospitalized patients between January 1, 2021, and June 30, 2024). The data set was divided into training (80%) and testing (20%) subsets, and model performance was evaluated using accuracy, recall, and F1 score. The validated model was applied to another data set with 80,917 medication prescriptions from 5859 hospitalized patients with at least one prescribed medication (during August and September 2024) to detect potential prescription errors. Sensitivity, specificity, and Cohen κ were calculated using manual expert review as the gold standard.

Results

The model achieved an accuracy of 87.28% and an F1 score of 0.80. It effectively identified medication names (F1=0.91) and adverse reactions (F1=0.85) but struggled with recommendation-related entities (F1=0.29). The model detected prescription errors in 0.96% of cases, with a sensitivity of 75.73% and specificity of 99.98%. The weighted κ score (0.7797) indicated substantial agreement with expert annotations.

Conclusion

The BERT-based model trained on Spanish-language corpora–based NER model demonstrated strong performance in identifying nonallergic cases (specificity, 99.98%; negative predictive value, 99.97%) and showed promise for clinical decision support. Despite moderate sensitivity (75.73%), these results highlight the feasibility of using Spanish-language NER models to enhance medication safety.
目的基于西班牙语语料库训练的bert模型,开发并验证命名实体识别(NER)模型,用于从非结构化电子病历中提取过敏相关信息。患者和方法使用来自匿名患者记录(2021年1月1日至2024年6月30日住院患者)的16,176个手动注释的过敏相关实体对模型进行微调。数据集被分为训练子集(80%)和测试子集(20%),使用准确率、召回率和F1分数来评估模型的性能。将验证后的模型应用于另一个数据集,该数据集包含5859名至少服用一种药物的住院患者(2024年8月至9月)的80,917张药物处方,以检测潜在的处方错误。灵敏度、特异性和Cohen κ以人工专家评审为金标准计算。结果该模型的准确率为87.28%,F1评分为0.80。它有效地识别了药物名称(F1=0.91)和不良反应(F1=0.85),但难以识别与推荐相关的实体(F1=0.29)。该模型检出率为0.96%,灵敏度为75.73%,特异性为99.98%。加权κ分数(0.7797)与专家注释基本一致。结论基于bert的模型在基于西班牙语语料库的NER模型上训练后,在识别非过敏病例方面表现出较强的性能(特异性为99.98%;阴性预测值为99.97%),为临床决策支持提供了希望。尽管敏感性中等(75.73%),但这些结果强调了使用西班牙语NER模型提高用药安全性的可行性。
{"title":"Natural Language Processing for Enhanced Clinical Decision Support in Allergy Verification for Medication Prescriptions","authors":"Juan Pablo Botero-Aguirre MS ,&nbsp;Michael Andrés García-Rivera MS","doi":"10.1016/j.mcpdig.2025.100244","DOIUrl":"10.1016/j.mcpdig.2025.100244","url":null,"abstract":"<div><h3>Objective</h3><div>To develop and validate a named entity recognition (NER) model based on BERT-based model trained on Spanish-language corpor, for extracting allergy-related information from unstructured electronic health records.</div></div><div><h3>Patients and Methods</h3><div>The model was fine-tuned using 16,176 manually annotated allergy-related entities from anonimized patient records (hospitalized patients between January 1, 2021, and June 30, 2024). The data set was divided into training (80%) and testing (20%) subsets, and model performance was evaluated using accuracy, recall, and F1 score. The validated model was applied to another data set with 80,917 medication prescriptions from 5859 hospitalized patients with at least one prescribed medication (during August and September 2024) to detect potential prescription errors. Sensitivity, specificity, and Cohen κ were calculated using manual expert review as the gold standard.</div></div><div><h3>Results</h3><div>The model achieved an accuracy of 87.28% and an F1 score of 0.80. It effectively identified medication names (F1=0.91) and adverse reactions (F1=0.85) but struggled with recommendation-related entities (F1=0.29). The model detected prescription errors in 0.96% of cases, with a sensitivity of 75.73% and specificity of 99.98%. The weighted κ score (0.7797) indicated substantial agreement with expert annotations.</div></div><div><h3>Conclusion</h3><div>The BERT-based model trained on Spanish-language corpora–based NER model demonstrated strong performance in identifying nonallergic cases (specificity, 99.98%; negative predictive value, 99.97%) and showed promise for clinical decision support. Despite moderate sensitivity (75.73%), these results highlight the feasibility of using Spanish-language NER models to enhance medication safety.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100244"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144571685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reliability of Cycle Applications for Pregnancy Planning and Contraception: A Systematic Review 妊娠计划和避孕周期应用的可靠性:系统综述
Pub Date : 2025-06-09 DOI: 10.1016/j.mcpdig.2025.100239
Isabell Rabe DMD, MPH , Jan P. Ehlers DVM, MA

Objective

To show the effectiveness of cycle applications in both areas of application—contraception and intended pregnancy.

Methods

A systematic review based on the PubMed and Google Scholar databases, with the addition of a hand search, was conducted from May 11, 2023, through April 11, 2024, to objectively answer this question. Of 1539 sources with matching search terms, 19 sources remained after checking for inclusion criteria according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses scheme. These were analyzed according to an evaluation scale regarding their quality in various areas. The average quality ratings and pregnancy probabilities of the studies were compared.

Results

Comparability within and between the subquestions was hardly possible owing to different presentation of results, bias risks, and mostly uncontrolled study designs. Applications for those wishing to become pregnant provided better quality ratings in some cases. There were indications that cycle applications shorten the time to achieving a desired pregnancy in cases of reduced fertility. In addition, some seem to have a similar contraceptive safety as the contraceptive pill but require significantly more compliance.

Conclusion

Independent, controlled studies with a diverse clientele of test subjects are necessary for a scientific classification. In addition, social, structural, and political adjustments are needed to enable individuals to make informed decisions about the use of cycle and fertility applications.
目的探讨周期应用在应用避孕和预期妊娠两方面的有效性。方法从2023年5月11日至2024年4月11日,基于PubMed和b谷歌Scholar数据库进行系统评价,并辅以人工检索,客观回答这一问题。在1539个具有匹配搜索词的来源中,根据系统评价和荟萃分析方案的首选报告项目检查纳入标准后,剩下19个来源。根据不同地区的质量评价量表对这些进行分析。比较研究的平均质量评分和怀孕概率。结果子问题内部和子问题之间几乎不可能具有可比性,因为结果的呈现方式不同,存在偏倚风险,而且大多数是不受控制的研究设计。在某些情况下,那些希望怀孕的人的申请提供了更高的质量评级。有迹象表明,在生育能力下降的情况下,周期应用缩短了实现预期怀孕的时间。此外,有些似乎具有与避孕药相似的避孕安全性,但需要更多的依从性。结论独立的、有不同测试对象的对照研究是科学分类的必要条件。此外,需要进行社会、结构和政治调整,使个人能够在使用周期和生育应用方面做出明智的决定。
{"title":"Reliability of Cycle Applications for Pregnancy Planning and Contraception: A Systematic Review","authors":"Isabell Rabe DMD, MPH ,&nbsp;Jan P. Ehlers DVM, MA","doi":"10.1016/j.mcpdig.2025.100239","DOIUrl":"10.1016/j.mcpdig.2025.100239","url":null,"abstract":"<div><h3>Objective</h3><div>To show the effectiveness of cycle applications in both areas of application—contraception and intended pregnancy.</div></div><div><h3>Methods</h3><div>A systematic review based on the PubMed and Google Scholar databases, with the addition of a hand search, was conducted from May 11, 2023, through April 11, 2024, to objectively answer this question. Of 1539 sources with matching search terms, 19 sources remained after checking for inclusion criteria according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses scheme. These were analyzed according to an evaluation scale regarding their quality in various areas. The average quality ratings and pregnancy probabilities of the studies were compared.</div></div><div><h3>Results</h3><div>Comparability within and between the subquestions was hardly possible owing to different presentation of results, bias risks, and mostly uncontrolled study designs. Applications for those wishing to become pregnant provided better quality ratings in some cases. There were indications that cycle applications shorten the time to achieving a desired pregnancy in cases of reduced fertility. In addition, some seem to have a similar contraceptive safety as the contraceptive pill but require significantly more compliance.</div></div><div><h3>Conclusion</h3><div>Independent, controlled studies with a diverse clientele of test subjects are necessary for a scientific classification. In addition, social, structural, and political adjustments are needed to enable individuals to make informed decisions about the use of cycle and fertility applications.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 4","pages":"Article 100239"},"PeriodicalIF":0.0,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145109430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mayo Clinic Proceedings. Digital health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1